期刊文献+

凋亡抑制蛋白XIAP在急性髓系白血病和淋巴瘤骨髓组织中的表达及意义 被引量:4

Expression and Clinical Significance of XIAP Protein in the Bone Marrow Tissue of Acute Myeloid Leukemia and Lymphoma
原文传递
导出
摘要 目的:研究凋亡抑制蛋白(XIAP)在白血病及淋巴瘤骨髓活检组织中的表达及意义。方法:采用免疫组织化学法检测10例急性髓系白血病,13例淋巴瘤,9例非恶性血液病患者骨髓活检组织中XIAP的表达水平。结果:XIAP蛋白在急性髓系白血病、淋巴瘤骨髓活检组织中的阳性表达积分均高于非恶性血液病,差异均有统计学意义(P<0.05)。结论:XIAP的表达水平与白血病及淋巴瘤的发生发展有一定关联,可能与其抑制肿瘤细胞的凋亡有关。 Objective: To investigate the expression and clinical significance of the X-linked inhibitor of apoptosis protein(XIAP) in bone marrow biopsy tissue of acute myeloid leukemia and lymphoma.Methods: The expression of XIAP was detected by immunohistochemical assay in the bone marrow biopsy tissue from 10 cases of acute myeloid leukemia,13 lymphoma and 9 patients without hematological malignancy.Results: The level of XIAP in the bone marrow tissue from acute myeloid leukemia and lymphoma was higher than those from control cases without hematological malignancy(P〈0.05).Conclusion:The increased expression of XIAP protein may contribute to the progression of acute myeloid leukemia and lymphoma,which may be relevant to its role as inhibitor of apoptosis.
出处 《现代生物医学进展》 CAS 2012年第20期3857-3859,共3页 Progress in Modern Biomedicine
关键词 白血病 淋巴瘤 XIAP Acute myeloid leukemia Lymphoma XIAP
  • 相关文献

参考文献4

二级参考文献66

共引文献9

同被引文献42

  • 1Kuendgen A, Germing U.Emerging treatment strategies for acute myeloid leukemia (AML)in the elderly[J].Cancer Treat Revi,2012,35(1):97-120.
  • 2Malfuson JV,Etienne A, Turlure P, et al.Risk factors and decision criteria for intensive chemotherapy in older pa- tients with acute myeloid leukemia [J]. Hacmatological, 2008,93 (2): 1806-1813.
  • 3Maritin BJ, Tempescul A, Moreau L, et al.Relapsing a- cute myeloid leukemia beginning with a penile localiza- tion[J].Am J Hematol,2011,86(2):193-194.
  • 4Fehniger TA, Uy GL, Trinkaus of high-dose lenalidomide as patients with acute myeloid 2011,117(6):1828-1833 K, et al.A phase 2 study initial therapy for older leukemia [J].Hematology,.
  • 5Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms[J].Blood,2002,100(5):2292-2302.
  • 6Hussain AR, Uddin S, Ahmed M, et al. Prognostic sig- nificance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling [J]. J Pathol, 2010,222 (2):180-190.
  • 7Felicitas T, Arnold G. Molecular pathogenesis of acute myeloid leukemia:A diverse disease with new perspec- tives[J]. Frontiers of Medicine in China,2010,4(4):356- 362.
  • 8Kantarjian H, Ravandi F, O'Brien S, et al. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia [J]. Blood,2010,116(2):4422-4429.
  • 9Juliuson G, Antunovic P, Derolf A, et al. Age and a- cute myeloid leukemia:real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry[J].Blood,2011,113(1):4179-4187.
  • 10Yoko I, Kousuke H, Fumio M, et al. Successful autologous stem cell transplantation for relapsed lymphoma with peripheral blood stem ceils cryopreserved for ten years [J]. Journal of Hematopoietic Cell Transplantation, 2012, 1(1): 29-32.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部